Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the anterior pituitary (HP:0011747)help
Parent Node:
expand
Hyperpituitarism (HP:0010514)help
..Starting node
..expand
Elevated circulating growth hormone concentration (HP:0000845)help
Term ID: 845
Name: Elevated circulating growth hormone concentration
Synonym: Elevated circulating somatotropin concentration; Growth hormone excess; Somatotropin excess
Definition: Acromegaly is a condition resulting from overproduction of growth hormone by the pituitary gland in persons with closed epiphyses, and consists chiefly in the enlargement of the distal parts of the body. The circumference of the skull increases, the nose becomes broad, the tongue becomes enlarged, the facial features become coarsened, the mandible grows excessively, and the teeth become separated. The fingers and toes grow chiefly in thickness.
Comments:
Reference: HP:0000845
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAdrenocorticotropic hormone excess (HP:0011749) help
..expandIncreased circulating gonadotropin level (HP:0000837) help
..expandIncreased circulating prolactin concentration (HP:0000870) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000845HP:0000845Elevated circulating growth hormone concentration0AIP CL E G H9049358ORPHA:963AcromegalyHP:0040281 - Very frequent95
HP:0000845HP:0000845Elevated circulating growth hormone concentration0AIP CL E G H9049358OMIM:102200Pituitary adenoma, growth hormone-secreting, 1.95
HP:0000845HP:0000845Elevated circulating growth hormone concentration0AIP CL E G H9049358ORPHA:99725Pituitary gigantismHP:0040281 - Very frequent95
HP:0000845HP:0000845Elevated circulating growth hormone concentration0AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040283 - Occasional95
HP:0000845HP:0000845Elevated circulating growth hormone concentration0CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040283 - Occasional636
HP:0000845HP:0000845Elevated circulating growth hormone concentration0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0000845HP:0000845Elevated circulating growth hormone concentration0CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional2
HP:0000845HP:0000845Elevated circulating growth hormone concentration0CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional102
HP:0000845HP:0000845Elevated circulating growth hormone concentration0CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4HP:0040282 - Frequent102
HP:0000845HP:0000845Elevated circulating growth hormone concentration0CDKN1B CL E G H10271785OMIM:610755Multiple endocrine neoplasia, type IV.102
HP:0000845HP:0000845Elevated circulating growth hormone concentration0CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional1
HP:0000845HP:0000845Elevated circulating growth hormone concentration0CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional
HP:0000845HP:0000845Elevated circulating growth hormone concentration0GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040283 - Occasional101
HP:0000845HP:0000845Elevated circulating growth hormone concentration0GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic.101
HP:0000845HP:0000845Elevated circulating growth hormone concentration0GPR101 CL E G H8355014963ORPHA:963AcromegalyHP:0040281 - Very frequent5
HP:0000845HP:0000845Elevated circulating growth hormone concentration0GPR101 CL E G H8355014963OMIM:300942Chromosome Xq26.3 duplication syndrome5
HP:0000845HP:0000845Elevated circulating growth hormone concentration0GPR101 CL E G H8355014963OMIM:300943PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA25
HP:0000845HP:0000845Elevated circulating growth hormone concentration0HPGD CL E G H32485154ORPHA:2796PachydermoperiostosisHP:0040283 - Occasional55
HP:0000845HP:0000845Elevated circulating growth hormone concentration0IGF1 CL E G H34795464OMIM:608747Insulin-Like growth factor I deficiency91
HP:0000845HP:0000845Elevated circulating growth hormone concentration0KCNJ11 CL E G H37676257ORPHA:79644Autosomal recessive hyperinsulinism due to Kir6.2 deficiency127
HP:0000845HP:0000845Elevated circulating growth hormone concentration0MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1.462
HP:0000845HP:0000845Elevated circulating growth hormone concentration0MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional462
HP:0000845HP:0000845Elevated circulating growth hormone concentration0MEN1 CL E G H42217010ORPHA:99725Pituitary gigantismHP:0040281 - Very frequent462
HP:0000845HP:0000845Elevated circulating growth hormone concentration0MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040283 - Occasional462
HP:0000845HP:0000845Elevated circulating growth hormone concentration0PDE11A CL E G H509408773ORPHA:1359Carney complexHP:0040282 - Frequent13
HP:0000845HP:0000845Elevated circulating growth hormone concentration0PMM2 CL E G H53739115ORPHA:79318PMM2-CDGHP:0040283 - Occasional150
HP:0000845HP:0000845Elevated circulating growth hormone concentration0PRKAR1A CL E G H55739388ORPHA:1359Carney complexHP:0040282 - Frequent134
HP:0000845HP:0000845Elevated circulating growth hormone concentration0PRKAR1A CL E G H55739388OMIM:160980Carney complex, type 1.134
HP:0000845HP:0000845Elevated circulating growth hormone concentration0SLCO2A1 CL E G H657810955ORPHA:2796PachydermoperiostosisHP:0040283 - Occasional13


Genes (16) :AIP CDH23 CDKN1A CDKN1B CDKN2B CDKN2C GNAS GPR101 HPGD IGF1 KCNJ11 MEN1 PDE11A PMM2 PRKAR1A SLCO2A1

Diseases (19) :ORPHA:963 OMIM:102200 ORPHA:99725 ORPHA:2965 ORPHA:91347 ORPHA:652 ORPHA:276152 OMIM:610755 ORPHA:562 OMIM:174800 OMIM:300942 OMIM:300943 ORPHA:2796 OMIM:608747 ORPHA:79644 OMIM:131100 ORPHA:1359 ORPHA:79318 OMIM:160980
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.